Skip to main content
Hansa Biopharma AB (publ) (STO:HNSA)
Sweden flag Sweden · Delayed Price · Currency is SEK
33.40
+0.18 (0.54%)
At close: Dec 5, 2025

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 30.80M SEK in the quarter ending September 30, 2025, a decrease of -36.70%. This brings the company's revenue in the last twelve months to 178.61M, down -5.69% year-over-year. In the year 2024, Hansa Biopharma AB had annual revenue of 171.32M with 27.76% growth.

Revenue (ttm)
178.61M
Revenue Growth
-5.69%
P/S Ratio
19.03
Revenue / Employee
1.34M
Employees
135
Market Cap
3.40B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024171.32M37.22M27.76%
Dec 31, 2023134.09M-20.43M-13.22%
Dec 31, 2022154.53M120.65M356.12%
Dec 31, 202133.88M27.78M455.56%
Dec 31, 20206.10M2.73M81.27%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Swedish Orphan Biovitrum AB 27.85B
Getinge AB 35.85B
Sectra AB 3.37B
Camurus AB 2.35B
Medicover AB 25.67B
Asker Healthcare Group AB 16.41B
BioArctic AB 1.92B
AddLife AB 10.53B
Revenue Rankings

Hansa Biopharma AB News

More News